Long COVID is a chronic condition that develops after a SARS-CoV-2 infection and lasts at least three months. It can affect nearly every organ system in the body, producing symptoms that range from persistent fatigue and brain fog to heart palpitations and shortness of breath. Roughly 1 in 5 people infected with COVID-19 don’t fully recover by six months, and for many, symptoms persist well beyond a year.
How Long COVID Is Diagnosed
There is no blood test, scan, or lab marker that can confirm long COVID. A positive COVID test isn’t even required for a diagnosis. Instead, your healthcare provider makes the call based on your health history, whether you had a known or suspected COVID-19 infection, and a physical examination of your current symptoms. This can be frustrating if you’re looking for a definitive answer, but it reflects the reality that long COVID is identified by its pattern of lingering or new symptoms rather than a single biomarker.
The minimum threshold is straightforward: symptoms that are present for at least three months after infection. Those symptoms can be ones that never went away after your initial illness, or they can be entirely new problems that showed up weeks later.
What It Feels Like
Long COVID doesn’t look the same in every person, which is part of what makes it so difficult to pin down. The CDC groups symptoms across several body systems, and many people experience problems in more than one category at once.
Neurological symptoms are among the most commonly reported. Brain fog, a term patients use to describe difficulty thinking or concentrating, is one of the hallmark complaints. Headaches, sleep disruption, dizziness when standing, pins-and-needles sensations, and changes in smell or taste round out the list. Depression and anxiety also fall under this umbrella, though it can be hard to separate what’s directly caused by the virus from the psychological toll of being chronically ill.
On the respiratory and cardiovascular side, people report shortness of breath, persistent coughing, chest pain, and a fast or pounding heartbeat. Some of these symptoms overlap with conditions like postural tachycardia syndrome, where your heart rate spikes when you stand up, a problem that many long COVID patients develop for the first time after their infection.
Fatigue deserves its own mention. It’s not ordinary tiredness. Many long COVID patients describe a deep, unrelenting exhaustion that worsens after physical or mental effort, sometimes called post-exertional malaise. Even small activities like a short walk or a focused conversation can trigger a crash that lasts hours or days.
Why It Happens
Researchers have identified several biological processes that likely contribute, though no single mechanism explains every case. One leading theory involves viral persistence: fragments of the virus, or even replication-capable virus, lingering in tissues long after the acute infection clears. A cross-sectional study published in The Lancet Infectious Diseases found a significant association between residual SARS-CoV-2 in tissues like the gut lining and the olfactory system (the tissue in your nose responsible for smell) and ongoing long COVID symptoms. In other words, the virus may not fully leave the body in some people, and its continued presence appears to drive symptoms.
Other proposed mechanisms include an immune system that stays in overdrive after the infection resolves, tiny blood clots (microclots) that impair circulation to organs, and damage to the energy-producing structures inside cells. These processes aren’t mutually exclusive. A single patient could have viral remnants triggering immune dysfunction, which in turn causes clotting abnormalities and energy problems. This layered biology helps explain why symptoms are so varied and why treatments that work for one person may not help another.
Who Is Most at Risk
A large meta-analysis published in Open Forum Infectious Diseases identified three standout risk factors. The strongest was being unvaccinated: people who hadn’t been vaccinated against COVID-19 had roughly twice the odds of developing long COVID compared to vaccinated individuals. Female sex was the second-largest risk factor, with women about 56% more likely to develop the condition than men. Pooled prevalence estimates put the rate at 45% in women versus 37% in men among studied populations. The third major factor was the severity of the initial infection. People who required intensive care had about 43% higher odds, and studies that included only hospitalized patients found a long COVID prevalence of 44%, compared to 29% among those who were never hospitalized.
Age plays a role too, but not in the direction you might expect. Adults over 18 had a pooled prevalence of about 35%, while children and adolescents came in at 23%. This doesn’t mean kids are immune, just that they develop the condition at somewhat lower rates.
Long COVID in Children
An estimated 10 to 20% of children and young adults develop long COVID after infection. Symptoms mirror many of those seen in adults: dizziness, elevated heart rate, fatigue, coughing, headaches, and changes in taste or smell. The condition is more likely to follow a symptomatic infection than a silent one, but it can develop even after cases with no noticeable symptoms at all.
What sets pediatric long COVID apart is the potential for new conditions to emerge. Some children go on to develop diabetes, chronic fatigue syndrome, or multisystem inflammatory syndrome in children (MIS-C), a serious condition involving inflammation across multiple organs. Symptoms can affect the heart, brain, and lungs simultaneously, making monitoring especially important for parents who notice their child isn’t bouncing back from a COVID infection the way they’d expect.
Recovery and Long-Term Outlook
A large population-based study published in The BMJ tracked recovery over two years and found a clear pattern: most improvement happens in the first six months, then progress slows considerably. About 23% of infected individuals hadn’t fully recovered by six months. That number dropped to roughly 18.5% at 12 months and 17.2% at 24 months. The gap between those numbers tells the story. Between six months and two years, only about 5 to 6 percentage points of additional people recovered, meaning the condition stabilized for many.
About 9% of participants in that study reported symptoms at every follow-up point across the full two years, representing a group with persistent, unrelenting illness. Another 12.5% experienced symptoms that came and went, cycling between better and worse periods. This relapsing-remitting pattern is something many patients describe: weeks of feeling almost normal, followed by a flare triggered by exertion, stress, or another infection.
The Workforce and Economic Toll
Long COVID’s effects extend well beyond individual health. A Brookings Institution analysis estimated that the condition reduced U.S. labor force participation by about 0.3 percentage points, translating to roughly 700,000 people either leaving the workforce or unable to enter it. A 2024 review found that people with long COVID are less likely to be employed overall, and those who do work tend to log fewer hours than their peers. Estimates of lost income among U.S. workers range from $101 billion to $430 billion annually, a range that reflects uncertainty in prevalence numbers but underscores the scale of the problem regardless of where the true figure falls.
For individuals, this often means navigating disability applications, reduced income, and the compounding stress of managing a condition that many employers and even some doctors still don’t fully understand. The economic data makes one thing clear: long COVID isn’t just a medical issue but a structural one, reshaping how millions of people relate to work, finances, and daily life.